Cargando…

Pioglitazone Induces Cardiomyocyte Apoptosis and Inhibits Cardiomyocyte Hypertrophy Via VEGFR-2 Signaling Pathway

BACKGROUND: Pioglitazone has been widely used as an insulin-sensitizing agent for improving glycemic control in patients with type 2 diabetes mellitus. However, cardiovascular risk and protective effects of pioglitazone remain controversial. OBJECTIVES: In this study, we investigated whether pioglit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhong, Wenliang, Jin, Wen, Xu, Shanghua, Wu, Yanqing, Luo, Shunxiang, Liang, Minlie, Chen, Lianglong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedade Brasileira de Cardiologia - SBC 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6122905/ https://www.ncbi.nlm.nih.gov/pubmed/29972411 http://dx.doi.org/10.5935/abc.20180108

Ejemplares similares

Telmisartan suppresses cardiac hypertrophy by inhibiting cardiomyocyte apoptosis via the NFAT/ANP/BNP signaling pathway
por: Li, Xiurong, et al.
Publicado: (2017)

Lycopene Inhibits Urotensin-II-Induced Cardiomyocyte Hypertrophy in Neonatal Rat Cardiomyocytes
por: Chao, Hung-Hsing, et al.
Publicado: (2014)

Relaxin ameliorates high glucose-induced cardiomyocyte hypertrophy and apoptosis via the Notch1 pathway
por: Wei, Xiao, et al.
Publicado: (2018)

VEGFR-2: One of Pioglitazone’s Signaling Pathways in the Heart
por: Minicucci, Marcos Ferreira, et al.
Publicado: (2018)

ADAM23 in Cardiomyocyte Inhibits Cardiac Hypertrophy by Targeting FAK‐AKT Signaling
por: Xiang, Mei, et al.
Publicado: (2018)

Effect of tanshinone IIA on cardiomyocyte hypertrophy and apoptosis in spontaneously hypertensive rats
por: JIANG, F.L., et al.
Publicado: (2013)

Buckwheat Rutin Inhibits AngII-induced Cardiomyocyte Hypertrophy via Blockade of CaN-dependent Signal Pathway
por: Chu, Jin-xiu, et al.
Publicado: (2014)

Endothelial Cells Regulate Physiological Cardiomyocyte Growth via VEGFR2-Mediated Paracrine Signaling
por: Kivelä, Riikka, et al.
Publicado: (2019)

The role of mAKAPβ in the process of cardiomyocyte hypertrophy induced by angiotensin II
por: GUO, HUIXIN, et al.
Publicado: (2015)

Role of Histone Demethylases in Cardiomyocytes Induced to Hypertrophy
por: Rosales, Wendy, et al.
Publicado: (2016)

Crosstalk between cardiomyocytes and noncardiomyocytes is essential to prevent cardiomyocyte apoptosis induced by proteasome inhibition
por: Guo, Fang, et al.
Publicado: (2020)

Spironolactone Inhibits Cardiomyocyte Hypertrophy by Regulating the Ca(2+)/Calcineurin/p-NFATc3 Pathway
por: Wang, Xin, et al.
Publicado: (2021)

Apigenin Attenuates Adriamycin-Induced Cardiomyocyte Apoptosis via the PI3K/AKT/mTOR Pathway
por: Yu, Wei, et al.
Publicado: (2017)

Shengmai Injection Suppresses Angiotensin II-Induced Cardiomyocyte Hypertrophy and Apoptosis via Activation of the AMPK Signaling Pathway Through Energy-Dependent Mechanisms
por: Li, Yiping, et al.
Publicado: (2019)

Cardiomyocyte BRAF and type 1 RAF inhibitors promote cardiomyocyte and cardiac hypertrophy in mice in vivo
por: Clerk, Angela, et al.
Publicado: (2022)

EPC-Derived Microvesicles Protect Cardiomyocytes from Ang II-Induced Hypertrophy and Apoptosis
por: Gu, Shenhong, et al.
Publicado: (2014)

Balancing functions of annexin A6 maintain equilibrium between hypertrophy and apoptosis in cardiomyocytes
por: Banerjee, P, et al.
Publicado: (2015)

Pioglitazone Protected against Cardiac Hypertrophy via Inhibiting AKT/GSK3β and MAPK Signaling Pathways
por: Wei, Wen-Ying, et al.
Publicado: (2016)

Curcumin Protects Neonatal Rat Cardiomyocytes against High Glucose-Induced Apoptosis via PI3K/Akt Signalling Pathway
por: Yu, Wei, et al.
Publicado: (2016)

AKIP1, a Cardiac Hypertrophy Induced Protein that Stimulates Cardiomyocyte Growth via the Akt Pathway
por: Yu, Hongjuan, et al.
Publicado: (2013)

Profilin modulates sarcomeric organization and mediates cardiomyocyte hypertrophy
por: Kooij, Viola, et al.
Publicado: (2016)

Effect of ligustilide on Ang II-induced hypertrophy in cardiomyocytes and the potential mechanisms
por: LU, QUN, et al.
Publicado: (2014)

Sumoylation-independent activation of Calcineurin-NFAT-signaling via SUMO2 mediates cardiomyocyte hypertrophy
por: Bernt, Alexander, et al.
Publicado: (2016)

Cardiomyocyte BRAF is a key signalling intermediate in cardiac hypertrophy in mice
por: Alharbi, Hajed O., et al.
Publicado: (2022)

SIRT6 Suppresses NFATc4 Expression and Activation in Cardiomyocyte Hypertrophy
por: Li, Zhenzhen, et al.
Publicado: (2019)

Etanercept protects rat cardiomyocytes against hypertrophy by regulating inflammatory cytokines secretion and cell apoptosis
por: Li, Q., et al.
Publicado: (2017)

Overexpression of FNTB and the activation of Ras induce hypertrophy and promote apoptosis and autophagic cell death in cardiomyocytes
por: Ding, Jie, et al.
Publicado: (2020)

Fluvastatin inhibits cardiomyocyte apoptosis after myocardial infarction through Toll pathway
por: Jia, Lili, et al.
Publicado: (2018)

Fluvastatin inhibits cardiomyocyte apoptosis after myocardial infarction through Toll pathway
por: Jia, Lili, et al.
Publicado: (2018)

Protective effect of pioglitazone on cardiomyocyte apoptosis in low-dose streptozotocin & high-fat diet-induced type-2 diabetes in rats
por: Bhandari, Uma, et al.
Publicado: (2015)

MALAT1 regulates hypertrophy of cardiomyocytes by modulating the miR-181a/HMGB2 pathway
por: Chen, Feng, et al.
Publicado: (2022)

Downregulation of Cypher induces apoptosis in cardiomyocytes via Akt/p38 MAPK signaling pathway
por: Xuan, Tianming, et al.
Publicado: (2020)

Inhibition of Receptor Interacting Protein Kinases Attenuates Cardiomyocyte Hypertrophy Induced by Palmitic Acid
por: Zhao, Mingyue, et al.
Publicado: (2016)

Angiotensin II Mediates Cardiomyocyte Hypertrophy in Atrial Cardiomyopathy via Epigenetic Transcriptional Regulation
por: Zheng, Liuying, et al.
Publicado: (2022)

Parkia speciosa Hassk. Empty Pod Extract Prevents Cardiomyocyte Hypertrophy by Inhibiting MAPK and Calcineurin-NFATC3 Signaling Pathways
por: Mustafa, Nor Hidayah, et al.
Publicado: (2022)

Sinapic Acid Inhibits Cardiac Hypertrophy via Activation of Mitochondrial Sirt3/SOD2 Signaling in Neonatal Rat Cardiomyocytes
por: Yun, Ui Jeong, et al.
Publicado: (2020)

HMGB1 enhances mechanical stress-induced cardiomyocyte hypertrophy in vitro via the RAGE/ERK1/2 signaling pathway
por: Zhang, Lei, et al.
Publicado: (2019)

DNA hydroxymethylation controls cardiomyocyte gene expression in development and hypertrophy
por: Greco, Carolina M., et al.
Publicado: (2016)

Regulation of myoglobin in hypertrophied rat cardiomyocytes in experimental pulmonary hypertension
por: Peters, E. L., et al.
Publicado: (2016)

Modeling Human Cardiac Hypertrophy in Stem Cell-Derived Cardiomyocytes
por: Ovchinnikova, Ekaterina, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_h50oe6ttojr5n4hio2i4fvck8k